United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Apr 16, 2026 · Filed Apr 16, 2026

On Apr 16, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$576.82 for US$4.79M under a trading plan, leaving 45,172 shares. Filed Apr 16, 2026 (Form 4).

Sold
8,300 shares
Price
US$576.82 average (US$574.03 to US$578.21)
Value
US$4.79M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockOption exercise8,300US$146.0353,472Direct
Apr 16, 2026Common StockSale200US$574.0353,272Direct
Apr 16, 2026Common StockSale1,640US$575.3751,632Direct
Apr 16, 2026Common StockSale1,800US$576.3849,832Direct
Apr 16, 2026Common StockSale3,366US$577.3946,466Direct
Apr 16, 2026Common StockSale1,294US$578.2145,172Direct

Source

View original at SEC

Related